The DOI matches its Crossref record; 78 of the 79 references it cites were found in a registry or an index.
Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD
Abstract
Early Alzheimer's disease (EAD) is the intermediary stage between mild cognitive impairment (MCI) and late-stage Alzheimer's disease (AD). The symptoms of EAD mirror the disease advancement between the two phases. Dementia, memory deficits, and cognitive decline are more pronounced as the disease progresses. Oxidative stress in brain is reported in MCI and AD, including lipid peroxidation indexed by protein-bound 4-hydroxy-2-nonenal (HNE). There are limited data regarding the proteomics analysis of brain from subjects with EAD and even less concerning the possible relationship of EAD HNE-modified brain proteins with HNE-modified proteins in MCI and AD. Proteomics was utilized to investigate excessively HNE-bound brain proteins in EAD compared to those in control. These new results provide potentially valuable insight into connecting HNE-bound brain proteins in EAD to those previously identified in MCI and AD, since EAD is a transitional stage between MCI and late-stage AD. In total, six proteins were found to be excessively covalently bound by HNE in EAD inferior parietal lobule (IPL) compared to age-related control brain. These proteins play roles in antioxidant defense (manganese superoxide dismutase), neuronal communication and neurite outgrowth (dihydropyriminidase-related protein 2), and energy metabolism (alpha-enolase, malate dehydrogenase, triosephosphate isomerase, and F1 ATPase, alpha subunit). This study shows that there is an overlap of brain proteins in EAD with previously identified oxidatively modified proteins in MCI and late-stage AD. The results are consistent with the hypothesis that oxidative stress, in particular lipid peroxidation, is an early event in the progression of AD, and is the first to identify in EAD identical brain proteins previously identified as HNE-modified in MCI and late-state AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MDH is oxidatively modified by HNE in early AD inferior parietal lobule (IPL) [55] and its carbonylation is induced by Aβ in vitro and in vivo [63,65,66].”
From Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease (2020) · cites this paper as [55]
In the citing paper
“The activities of LDH, aconitase, and ATP synthase are significantly decreased as a result of oxidation [54,55,56,61]”
From Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease (2020) · cites this paper as [55]
In the citing paper
“The carbonylation of ATP synthase is induced in vivo by Aβ [73], and it is significantly modified by HNE in MCI hippocampus and IPL [56], early AD IPL [55], and late AD IPL [54] in addition to being significantly nitrated in late AD hippocampus [57].”
From Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease (2020) · cites this paper as [55]
In the citing paper
“however, the activity of MDH is significantly increased [55].”
From Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease (2020) · cites this paper as [55]
In the citing paper
“MnSOD is oxidatively modified by HNE in early AD IPL, resulting in a significant decrease in enzyme activity [55]”
From Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease (2020) · cites this paper as [55]
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation
Coyle, J. T., Price, D. L., & DeLong, M. R. (1983) · Science · doi:10.1126/science.6338589 · Cited by 3,052
Oxidative stress hypothesis in Alzheimer’s disease
Markesbery, W. R. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00629-6 · Cited by 2,383
Reaume, A. G., Elliott, J. L., Hoffman, E. K., Kowall, N. W., Ferrante, R. J., Siwek, D. F., Wilcox, H. M., Flood, D. G., Beal, M. F., Brown, R. H., et al. (1996) · Nature Genetics · doi:10.1038/ng0596-43 · Cited by 1,285
Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid β-peptide
Butterfield, D. A., Drake, J., Pocernich, C., & Castegna, A. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02173-6 · Cited by 1,114
Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment
Scheff, S. W., Price, D. A., Schmitt, F. A., & Mufson, E. J. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.012 · Cited by 1,017
Butterfield, D. A., & Lauderback, C. M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00794-3 · Cited by 1,013
Keller, J. N., Kindy, M. S., Holtsberg, F. W., St. Clair, D. K., Yen, H.-C., Germeyer, A., Steiner, S. M., Bruce-Keller, A. J., Hutchins, J. B., & Mattson, M. P. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-02-00687.1998 · Cited by 863
Hensley, K., Hall, N., Subramaniam, R., Cole, P., Harris, M., Aksenov, M., Aksenova, M., Gabbita, S. P., Wu, J. F., Carney, J. M., et al. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65052146.x · Cited by 779 · cited 1×
“…(indexed by free or protein-bound 4-hydroxy-2- nonenal (HNE)), and DNA and RNA oxidation (indexed by 8- hydroxy-2-deoxyguanosine and 8-hydroxyguanosine, respectively) have been reported from subjects with AD and MCI (Butterfield et al., 2006b,c, 2007; Hensley et al., 1995; Lauderback et al., 2001).”
Neuron numbers and dendritic extent in normal aging and Alzheimer’s disease
Coleman, P. D., & Flood, D. G. (1987) · Neurobiology of Aging · doi:10.1016/0197-4580(87)90127-8 · Cited by 772
Flagged first, then by citations
1 of the 79 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–191 of 191
Gu, L., & Robinson, R. A. S. (2016) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201600015 · Cited by 40
Zhang, S., Eitan, E., & Mattson, M. P. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.13957 · Cited by 38
Allowitz, K. V., Taylor, J., Harames, K., Yoo, J., Baloch, O. A., & Ramana, K. V. (2024) · Current Neuropharmacology · doi:10.2174/011570159x342720241014164650 · Cited by 38
Wang, G., Li, H., & Khan, M. F. (2012) · Free Radical Research · doi:10.3109/10715762.2012.727209 · Cited by 37
Pharmacological approaches for Alzheimer’s disease: neurotransmitter as drug targets
Prakash, A. K., Kalra, J., Mani, V., Ramasamy, K., & Majeed, A. B. A. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.988709 · Cited by 35
Reactive Aldehydes and Neurodegenerative Disorders
Matveychuk, D., Dursun, S. M., Wood, P. L., & Baker, G. B. (2011) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.5455/bcp.19691231040000 · Cited by 33
Neuroproteomics Approaches to Decipher Neuronal Regeneration and Degeneration
Sun, F., & Cavalli, V. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r900003-mcp200 · Cited by 32
Misfolded proteins and neurodegeneration: role of non-native cytochrome c in cell death
Santucci, R., Sinibaldi, F., Patriarca, A., Santucci, D., & Fiorucci, L. (2010) · Expert Review of Proteomics · doi:10.1586/epr.10.50 · Cited by 33
Protein carbonylation in human bronchial epithelial cells exposed to cigarette smoke extract
Colombo, G., Garavaglia, M. L., Astori, E., Giustarini, D., Rossi, R., Milzani, A., & Dalle‐Donne, I. (2019) · Cell Biology and Toxicology · doi:10.1007/s10565-019-09460-0 · Cited by 32
Jové, M., Mota‐Martorell, N., Torres, P., Ayala, V., Portero‐Otín, M., Ferrer, I., & Pamplona, R. (2021) · Life · doi:10.3390/life11050388 · Cited by 31
Cao, G., Ding, C., Ruan, D., Chen, Z., Wu, H., Hong, Y., & Cai, Z. (2018) · Food Control · doi:10.1016/j.foodcont.2018.10.013 · Cited by 31
Butterfield, D. A. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.10.036 · Cited by 31
Kawasaki, H., Ikeda, K., Shigenaga, A., Baba, T., Takamori, K., Ogawa, H., & Yamakura, F. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.10.688 · Cited by 30
Juhász, G. D., Földi, I., & Penke, B. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.02.008 · Cited by 29
Dimethyl Fumarate is a Potential Therapeutic Option for Alzheimer’s Disease
Sun, X., Suo, X., Xia, X., Yu, C., & Dou, Y. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215074 · Cited by 32
Oxidative Stress in Brain in Amnestic Mild Cognitive Impairment
Butterfield, D. A. (2023) · Antioxidants · doi:10.3390/antiox12020462 · Cited by 29
Proteomic analysis of mitochondrial dysfunction in neurodegenerative diseases
Rodolfo, C., Ciccosanti, F., Giacomo, G. D., Piacentini, M., & Fimia, G. M. (2010) · Expert Review of Proteomics · doi:10.1586/epr.10.43 · Cited by 29
Targeted quantitative analysis of synaptic proteins in Alzheimer’s disease brain
Chang, R. Y. K., Etheridge, N., Dodd, P. R., & Nouwens, A. S. (2014) · Neurochemistry International · doi:10.1016/j.neuint.2014.05.011 · Cited by 28
Subcellular Redox Targeting: Bridging in Vitro and in Vivo Chemical Biology
Long, M. J. C., Poganik, J. R., Ghosh, S., & Aye, Y. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.6b01148 · Cited by 26
Cenini, G., Fiorini, A., Rukhsana Sultana, A., Marzia Perluigi, A., Cai, J., Klein, J. B., Head, E., & Butterfield, D. A. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.08.006 · Cited by 26
Mehder, R. H., Bennett, B. M., & Andrew, R. D. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191067 · Cited by 26
Knopp, R. C., Lee, S., Hollas, M. A. R., Nepomuceno, E., González, D., Tam, K. A., Aamir, D., Wang, Y., Pierce, E. N., BenAissa, M., et al. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101486 · Cited by 25
Impact of common ALDH2 inactivating mutation and alcohol consumption on Alzheimer’s disease
Seike, T., Chen, C., & Mochly‐Rosen, D. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1223977 · Cited by 28
Rauniyar, N., & Prókai, L. (2011) · Journal of Mass Spectrometry · doi:10.1002/jms.1978 · Cited by 25
Ni, S., Zhou, Y., Chen, Y., Du, X., & Zhang, S. (2019) · The FASEB Journal · doi:10.1096/fj.201901290r · Cited by 25
Matsumoto, A. (2016) · Nippon Eiseigaku Zasshi (Japanese Journal of Hygiene) · doi:10.1265/jjh.71.55 · Cited by 24
Hill, R. L., Singh, I. N., Wang, J. A., Kulbe, J. R., & Hall, E. D. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113322 · Cited by 25
Timosaponin-BII inhibits the up-regulation of BACE1 induced by Ferric Chloride in rat retina
Huang, J.-F., Shang, L., Liu, P., Zhang, M.-Q., Chen, S., Chen, D., Fan, C.-L., Wang, H., & Xiong, K. (2012) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-12-189 · Cited by 21
Cafe, S. L., Nixon, B., Ecroyd, H. W., Martin, J. H., Skerrett-Byrne, D. A., & Bromfield, E. G. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.660626 · Cited by 23
Li, Q., Sadhukhan, S., Berthiaume, J. M., Ibarra, R., Tang, H., Deng, S., Hamilton, E., Nagy, L. E., Tochtrop, G. P., & Zhang, G. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.01.005 · Cited by 22
FK506 attenuates intracerebroventricular streptozotocin-induced neurotoxicity in rats
Arora, R., Kumar, K., & Deshmukh, R. R. (2013) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32836546db · Cited by 22
Protein Adducts of Aldehydic Lipid Peroxidation Products
Maier, C. S., Chavez, J. D., Wang, J., & Wu, J. (2010) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(10)73016-0 · Cited by 22
Hsp70.1 carbonylation induces lysosomal cell death for lifestyle-related diseases
Yamashima, T., Seike, T., Oikawa, S., Kobayashi, H., Kido, H., Yanagi, M., Yamamiya, D., Li, S., Boontem, P., & Mizukoshi, E. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.1063632 · Cited by 21
Current Advances in Mitochondrial Targeted Interventions in Alzheimer’s Disease
de Sousa, T. S., Moreira, P. I., & Cardoso, S. (2023) · Biomedicines · doi:10.3390/biomedicines11092331 · Cited by 22
Wu, J., Stevens, J. F., & Maier, C. S. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100255 · Cited by 21
Involvement of stat3 in mouse brain development and sexual dimorphism: A proteomics approach
Domenico, F. D., Casalena, G., Rukhsana Sultana, A., Cai, J., Pierce, W. M. J., Marzia Perluigi, A., Cini, C., Baracca, A., Solaini, G., Lenaz, G., et al. (2010) · Brain Research · doi:10.1016/j.brainres.2010.09.074 · Cited by 21
Uddin, M. S., Uddin, G. M. S., Begum, M. M., Begum, Y., Herrera-Calderón, O., Islam, M. M., & Abdel‐Daim, M. M. (2017) · Journal of Pharmacy and Nutrition Sciences · doi:10.6000/1927-5951.2017.07.03.10 · Cited by 20
Implication of the cooking oil-peroxidation product “hydroxynonenal” for Alzheimer’s disease
Yamashima, T., Seike, T., Mochly‐Rosen, D., Chen, C., Kikuchi, M., & Mizukoshi, E. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1211141 · Cited by 20
Wang, G., Wakamiya, M., Wang, J., Ansari, G. A. S., & Khan, M. F. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.10.402 · Cited by 21
Almaguer, J., Hindle, A., & Lawrence, J. J. (2023) · Antioxidants · doi:10.3390/antiox12111921 · Cited by 19
Campos-Pinto, I., Méndez, L., Schouten, J. A., Wilkins, J., Fedorova, M., Pitt, A. R., Davis, P. J., & Spickett, C. M. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.05.008 · Cited by 17
Determinants of short- and long-term survival from colorectal cancer in very elderly patients
Sheridan, J., Walsh, P., Kevans, D., Cooney, T., O’Hanlon, S., Nolan, B., White, A., McDermott, E., Sheahan, K. D., O’Shea, D., et al. (2014) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2014.04.005 · Cited by 18
Milic, I., Kipping, M., Hoffmann, R., & Fedorova, M. (2015) · Journal of Mass Spectrometry · doi:10.1002/jms.3713 · Cited by 17
Hill, R. L., Singh, I. N., Wang, J. A., & Hall, E. D. (2018) · Journal of Neurotrauma · doi:10.1089/neu.2018.5946 · Cited by 17
4-Hydroxynonenal Immunoreactivity Is Increased in the Frontal Cortex of 5XFAD Transgenic Mice
Shin, S.-W., Kim, D.-H., Jeon, W. K., & Han, J. (2020) · Biomedicines · doi:10.3390/biomedicines8090326 · Cited by 17
Mehan, S., Arora, R., Sehgal, V., Sharma, D., & Sharm, G. (2012) · InTech eBooks · doi:10.5772/25318 · Cited by 17
Identification of 4-hydroxynonenal-modified proteins in human osteoarthritic chondrocytes
Geib, T., Iacob, C., Jribi, R., Fernandes, J., Benderdour, M., & Sleno, L. (2020) · Journal of Proteomics · doi:10.1016/j.jprot.2020.104024 · Cited by 17
Time-dependent alterations of cerebral proteins following short-term normobaric hyperoxia
Hinkelbein, J., Feldmann, R. E., & Kalenka, A. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-009-0365-1 · Cited by 16
Ghoweri, A. O., Gagolewicz, P. J., Frazier, H. N., Gant, J. C., Andrew, R. D., Bennett, B. M., & Thibault, O. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200617 · Cited by 16
Dynamic Interplay between Copper Toxicity and Mitochondrial Dysfunction in Alzheimer’s Disease
Tassone, G., Kola, A., Valensin, D., & Pozzi, C. (2021) · Life · doi:10.3390/life11050386 · Cited by 16
Xu, J., Li, H., & Knight, W. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.322463 · Cited by 16
Heterogeneity of peptide adducts with carbonylated lipid peroxidation products
Milic, I., Melo, T., Domingues, M. R., Domingues, P. M., & Fedorova, M. (2015) · Journal of Mass Spectrometry · doi:10.1002/jms.3568 · Cited by 15
Zhao, T., Miao, H., Song, Z., Li, Y., Xia, N., Zhang, Z., & Zhang, H. (2023) · Environmental Science and Pollution Research · doi:10.1007/s11356-023-27303-8 · Cited by 14
Gesslbauer, B., Kuerzl, D., Valpatic, N., & Bochkov, V. N. (2018) · Antioxidants · doi:10.3390/antiox7090116 · Cited by 14
Alzheimer's and Parkinson's diseases: An environmental proteomic point of view
Demartini, D. R., Schilling, L. P., da Costa, J. C., & Carlini, C. R. (2014) · Journal of Proteomics · doi:10.1016/j.jprot.2014.04.014 · Cited by 14
Perspectives on Alzheimer’s Disease Treatment Based on Counteracting Oxidative Stress
Bilski, R., Dąbkowski, S., Kozieł, I., Kozicki, M., Małachowska, A., Przygocki, M., & Tyska, O. (2025) · Biomolecules · doi:10.3390/biom15091345 · Cited by 13
Das, N. K., & Jana, C. K. (2015) · Free Radical Research · doi:10.3109/10715762.2015.1017477 · Cited by 11
How to Use 2D Gel Electrophoresis in Plant Proteomics
Rabilloud, T. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-631-3_4 · Cited by 11
Treatment of age-related decreases in GTP levels restores endocytosis and autophagy
Santana-Martínez, R. A., McWhirt, J., & Brewer, G. J. (2025) · GeroScience · doi:10.1007/s11357-025-01786-4 · Cited by 11
Li, H., Tan, L., Yang, H., Pang, W., Xu, T., & Jiang, Y.-G. (2018) · Nutritional Neuroscience · doi:10.1080/1028415x.2018.1471251 · Cited by 10
Identification of dihalogenated proteins in rat intestinal mucosa injured by indomethacin
Takagi, T., Naito, Y., Okada, H., Okayama, T., Mizushima, K., Yamada, S., Fukumoto, K., Inoue, K., Takaoka, M., Oya‐Ito, T., et al. (2011) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.10-93 · Cited by 9
Clinical implications of lipid peroxides levels in plasma and tumor tissue in breast cancer patients
Scandolara, T. B., da Silva, J. C., Alves, F. M., Malanowski, J., de Oliveira, S. T., Maito, V. T., Rech, D., Panis, C., & Bonvicino, C. R. (2022) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2022.106639 · Cited by 9
Unregulated Lipid Peroxidation in Neurological Dysfunction
Shichiri, M., Yoshida, Y., & Niki, E. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-410527-0.00004-1 · Cited by 10
Mehder, R. H., Bennett, B. M., & Andrew, R. D. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201024 · Cited by 8
Puoliväli, J. T., Nurmi, A., Miettinen, T.-K., Soleti, A., Riccardino, F., Kalesnykas, G., Heikkinen, T., Vartiainen, N. E., Pussinen, R., Tähtivaara, L., et al. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110881 · Cited by 7
Ferreira, D. J. S., Sellitti, D. F., & Lagranha, C. J. (2016) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174416000246 · Cited by 7
Grasso, G., & Axelsen, P. H. (2016) · Journal of Mass Spectrometry · doi:10.1002/jms.3897 · Cited by 7
PHARMACOLOGICAL EVALUATION OF TRIPHALA CHURNA INSTREPTOZOTOCIN (I. C. V.) INDUCED DEMENTIA IN RATS
Deka, P., & Kumar, A. (2018) · International Journal of Pharmacy and Pharmaceutical Sciences · doi:10.22159/ijpps.2018v10i3.22795 · Cited by 7
Zhang, H. N., Wu, J., Jin, T., Chang, M. J. W., & Sun, L. (2012) · Neurological Sciences · doi:10.1007/s10072-012-1063-4 · Cited by 6
Dodson, M. B., Benavides, G. A., Darley-Usmar, V. M., & Zhang, J. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.812810 · Cited by 7
Application of regulation of reactive oxygen species and lipid peroxidation to disease treatment
Shichiri, M., Suzuki, H., Isegawa, Y., & Tamai, H. (2022) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.22-61 · Cited by 6
Ferroptosis in Nervous System Diseases
Wan, J., Yang, X., & Wang, J. (2019) · Springer eBooks · doi:10.1007/978-3-030-26780-3_10 · Cited by 5
Jeong, J., Lee, J., & Lee, K. (2012) · InTech eBooks · doi:10.5772/31763 · Cited by 3
Oxidative Stress in Alzheimer's Disease: Targeting with Nanotechnology
Behera, R. K., Goel, S., Domann, N., Mahapatra, A., Hosmane, N. S., Evans, T., & Das, B. C. (2014) · Cited by 3
Protein Carbonylation in Brains of Subjects with Selected Neurodegenerative Disorders
Reed, T. T., & Butterfield, D. A. (2017) · Wiley eBooks · doi:10.1002/9781119374947.ch8 · Cited by 3
Saha, T., Vats, T., & Mehan, S. (2026) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2026.2671714 · Cited by 2
Ramachandran, S., M, S. R., Liza, U., PS, L. P., & SARISHMA, K. (2019) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2019.v12i3.30720 · Cited by 2
Mitochondrial vulnerability to aldehydic load and the role mitochondrial aldehyde dehydrogenases
Seike, T., & Mochly‐Rosen, D. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108285 · Cited by 1
Responses of HSC70 expression in diencephalon to iron deficiency anemia in rats
Kawano, F., Oke, Y., Nomura, S., Fujita, R., Ohira, T., Nakai, N., & Ohira, Y. (2011) · The Journal of Physiological Sciences · doi:10.1007/s12576-011-0164-9 · Cited by 1
Pamplona, R., Jové, M., Pradas, I., Mota‐Martorell, N., & Ferrer, I. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817990-1.00008-1 · Cited by 1
Lee, M. T. W., Mahy, W., & Rackham, M. D. (2021) · RSC Medicinal Chemistry · doi:10.1039/d1md00113b · Cited by 1
Sahni, J. K., Doggui, S., Dao, L. H., & Ramassamy, C. (2011) · Wiley eBooks · doi:10.1002/9780470960844.ch10
Trichloroethylene-Induced Oxidative Stress and Autoimmunity
Khan, M. F., & Wang, G. (2014) · Molecular and integrative toxicology · doi:10.1007/978-1-4471-6311-4_4
Genetic dissection of models for neuroinflammation and neurodegeneration
Harnesk, K. (2009) · Figshare
Roe, M. R. (2010) · University of Minnesota Digital Conservancy (University of Minnesota)
Divergence in Neuronal Calcium Dysregulation in Brain Aging and Animal Models of AD
Ghoweri, A. O. (2020) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2020.521
Chemokines and redox homeostasis in aging: A dynamic relationship
González, G. O., & Borrás, C. (2026) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2026.112185
Inflammation and Oxidation: A Link in Alzheimer’s Disease Pathogenesis
Hensley, K. (2013) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-1-62703-598-9_3
Metadata
- Authors
- Reed, T. T., Pierce, W. M., Markesbery, W. R., & Butterfield, D. A.
- Affiliations
- University of Kentucky (US)
- University of Louisville (US)
- Corresponding author
- Butterfield, D. Allan
- Venue
- Brain Research
- Publisher
- Elsevier BV
- Published
- 2009-06
- Volume
- 1274
- Pages
- 66-76
- ISSN
- 0006-8993 (ISSN-L)
- OpenAlex
- W2076534507
- Cited by
- 190
- References
- 79
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 1 · 2023: 8 · 2022: 7 · 2021: 13 · 2020: 12 · 2019: 9 · 2018: 11 · 2017: 8 · 2016: 14 · 2015: 13 · 2014: 14 · 2013: 16 · 2012: 16
- FWCI
- 13.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Brain Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG-0288383, P01AG010836, P01AG005119, AG 10836, AG0 5119)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- early Alzheimer's disease, 4-hydroxynonenal, lipid peroxidation, oxidative stress, protein oxidation, brain proteomics, inferior parietal lobule, manganese superoxide dismutase, alpha-enolase, malate dehydrogenase, triosephosphate isomerase, F1-ATPase, antioxidant defense, energy metabolism, neural communication, disease progression
- MeSH terms
- Aged, Aged, 80 and over, Aldehydes, Alzheimer Disease, Brain, Female, Humans, Male, Proteins, Blotting, Western, Lipid Peroxidation, Oxidative Stress, Disease Progression, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Proteomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review